As of April 16, 2025, Aura Biosciences (AURA) has a market cap of $0.28 billion USD. According to our data, Aura Biosciences is ranked No.6591 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.28 B |
-31.87%
|
Dec 31, 2024 | $0.41 B |
-7.22%
|
Dec 29, 2023 | $0.44 B |
-15.62%
|
Dec 30, 2022 | $0.52 B |
-38.16%
|
Dec 31, 2021 | $0.85 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Immunocore
IMCR
|
$1.35 B |
-0.000 M
|
![]() UK
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.70 B |
0.000 M
|
![]() USA
|
Market Cap | = | AURA Stock Price | * | AURA Shares Outstanding |
= | $5.57 | * | 50.23 M | |
= | $0.28 B |